ELLIS ANDREA sold 77.7% of their position (64.92K shares) of BRIDGEBIO PHARMA, INC. on the open market
Open‑market sale worth $4.21M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/6/2026ACC: 0001470831-26-000252
-64.92K
Net shares
Net seller
$4.21M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
64.92K acquired · 129.84K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+64.92K
Price / share
$8.45
Trade value
$548.58K
% of position
349.2%
3/4/2026
18.59K→83.51K
Common Stock
Direct
Shares
−64.92K
Price / share
$64.87
Trade value
$4.21M
% of position
77.7%
3/4/2026
83.51K→18.59K
Total
Net shares
+0.00
Net value
-$3.66M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/4/2026 | M · Option Exercise | +64.92K | $8.45 | $548.58K | 349.2% | 18.59K | 83.51K |
| Common Stock Direct | 3/4/2026 | S · Sale | −64.92K | $64.87 | $4.21M | 77.7% | 83.51K | 18.59K |
| Total | +0.00 | -$3.66M | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
64.92K shares
Shares
−64.92K
Strike price
8.45
Held after
0.00
Exercisable
—
3/4/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock64.92K shares | 3/4/2026 | M · Option Exercise | −64.92K | 8.45 | — | 0.00 |